Skip to main content
Home > The Daily Extra > Financial News

Chronological Index of : Financial News

 Current Issue
  • FINANCIAL NEWS: Editas seeking valuation above $600M

    Gene editing company Editas Medicine Inc. (Cambridge, Mass.) amended its proposed IPO on NASDAQ and plans to sell 5.9 million shares at $16-$18. At $17, it would raise $100.3 million and be valued at $606.9 million. …

    Published on 1/25/2016
  • FINANCIAL NEWS: Pharmas, U.K. schools launch L40M Apollo fund

    Three pharmas and the tech transfer offices of three U.K. universities launched the L40 million ($57 million) Apollo Therapeutics Fund to support development of early stage projects arising from the universities. Apollo…

    Published on 1/25/2016
  • FINANCIAL NEWS: Akili raises $30.5M for therapeutic games

    Akili Interactive Labs Inc. (Boston, Mass.) raised $30.5 million in a venture round from investors including Jazz Venture Partners, Canepa Advanced Healthcare Fund and PureTech Health plc (LSE:PRTC). Akili is developing…

    Published on 1/22/2016
  • FINANCIAL NEWS: iCarbonX raising RMB700M

    Artificial intelligence newco iCarbonX has raised RMB100 million ($15.2 million) from Zhongyuan Union Stem Cell Bioengineering Corp. (Shanghai:600645) as part of a planned RMB700 million ($106.4 million) round, …

    Published on 1/22/2016
  • FINANCIAL NEWS: Abingworth closes $105M risk-sharing fund

    Abingworth closed a $105 million fund dedicated to risk-sharing investments in late-stage clinical therapeutic programs from biotech and pharma companies. The firm will invest its eleventh fund, Abingworth Clinical Co-…

    Published on 1/21/2016
  • FINANCIAL NEWS: bioMerieux spinout bioTheranostics raises $32M

    bioTheranostics Inc. raised $32 million in an equity round and said it will spin out from parent company bioMerieux S.A. (Euronext:BIM). MVM Life Science Partners led the round, in which Canepa Advanced Healthcare Fund …

    Published on 1/21/2016
  • FINANCIAL NEWS: Financial tracks

    Atlas Venture hired Tariq Kassum as an entrepreneur-in-residence. Kassum was VP and head of oncology business development at Takeda Pharmaceutical Co. Ltd. (Tokyo:4502).

    Published on 1/21/2016
  • FINANCIAL NEWS: vasopharm raises EUR 20M

    vasopharm GmbH raised EUR 20 million ($21.8 million) in a venture round co-led by existing investors Entrepreneurs Fund, Heidelberg Capital Private Equity and new investor Fort Rock Capital. Existing investors Bayern …

    Published on 1/21/2016
  • FINANCIAL NEWS: BeiGene sets IPO terms

    Cancer company BeiGene Ltd. (Beijing, China) set terms for its IPO on NASDAQ and now hopes to sell 5.5 million ADSs at $22-$24. At $23, it would raise $126.5 million and be valued at $685.9 million. Goldman Sachs, …

    Published on 1/20/2016
  • FINANCIAL NEWS: Chinese firms back Cocoon's L500M fund

    Cocoon Networks launched a L500 million ($715 million) London-based VC fund to invest in European startups. The fund, backed by Chinese investment companies China Equity Group and Hanxin Capital, will invest in start-…

    Published on 1/20/2016
  • FINANCIAL NEWS: AveXis files for $115M IPO

    Gene therapy company AveXis Inc. (Chicago, Ill.) filed to raise up to $115 million in an IPO on NASDAQ underwritten by Goldman Sachs, Jefferies, BMO Capital Markets and Chardan. In 1H17, AveXis hopes to begin pivotal …

    Published on 1/19/2016
  • FINANCIAL NEWS: Twist raises $61M in series D

    Twist Bioscience Corp. (San Francisco, Calif.) raised $61 million in a series D round. New investors WuXi Healthcare Ventures, Arch Overage Fund, Merieux Developpement, Cormorant Asset Management and Boris Nikolic …

    Published on 1/19/2016
  • FINANCIAL NEWS: UCL launches L50M fund

    University College London launched the UCL Technology Fund with L50 million ($71.5 million), which it plans to invest over five years in academic research it believes has commercial potential, including licensing …

    Published on 1/19/2016
  • FINANCIAL NEWS: 20/20 GeneSystems raises $4.5M in series A

    Diagnostic play 20/20 GeneSystems Inc. (Rockville, Md.) raised $4.5 million in a series A round. Investors included Ping An Ventures, which is the venture capital division of China's largest insurance company, and …

    Published on 1/15/2016
  • FINANCIAL NEWS: Biotechs end week with more losses

    Biotech stocks sank Friday along with the broader markets, ending a dismal week with heavy losses. The BioCentury 100 index slipped 129.90 (2%) to 5,185.32, as decliners outpaced gainers 83-16. The index fell 356.51 (6…

    Published on 1/15/2016
  • FINANCIAL NEWS: Oncobiologics files for IPO

    Oncobiologics Inc. (Cranbury, N.J.) filed to raise up to $115 million in an IPO on NASDAQ underwritten by Jefferies, Barclays and Cantor Fitzgerald. This year, the company intends to begin Phase III trials of two …

    Published on 1/15/2016
  • FINANCIAL NEWS: Modest rally for biotech stocks

    Biotech stocks rebounded Thursday, recovering some of the losses the battered sector has endured thus far in 2016. The BioCentury 100 index rose 188.05 (4%) to 5,309.22 on Thursday, with gainers outnumbering decliners …

    Published on 1/14/2016
  • FINANCIAL NEWS: Financial tracks

    Oak HC/FT named Ezekiel Emanuel a venture partner. He will continue to serve as vice provost of global initiatives, medical ethics and health policy department chair, and a professor at the University of Pennsylvania. …

    Published on 1/13/2016
  • FINANCIAL NEWS: Gene control play Syros raises $40M

    Syros Pharmaceuticals Inc. (Watertown, Mass.) raised $40 million in a venture round led by Deerfield Management. Fellow new investor Casdin Capital also participated, as did existing investors Fidelity, WuXi Healthcare …

    Published on 1/13/2016
  • FINANCIAL NEWS: Tmunity raises $10M for T cells

    Tmunity Therapeutics Inc. (Philadelphia, Penn.) raised $10 million in a venture round from Penn Medicine and Lilly Asia Ventures to develop engineered T cell immunotherapies for cancer and infectious and autoimmune …

    Published on 1/13/2016
  • FINANCIAL NEWS: Kodiak raises $34M in series B

    Ophthalmic company Kodiak Sciences Inc. (Palo Alto, Calif.) raised $34 million in a series B round led by an undisclosed U.S. investor. The company, formerly Oligasis LLC, did not respond to inquiries.Kodiak's pipeline …

    Published on 1/12/2016
  • FINANCIAL NEWS: Accelerator debuts Lodo

    Accelerator Corp. (Seattle, Wash.) formed its second New York City biotech with the launch of Lodo Therapeutics Corp., which is developing small molecules from microbial sources such as soil bacteria and the human …

    Published on 1/11/2016
  • FINANCIAL NEWS: Aelix raises EUR 11.5M in series A

    HIV vaccine developer Aelix Therapeutics S.L. (Barcelona, Spain) raised EUR 11.5 million ($12.5 million) in a series A round led by Ysios Capital. The Johnson & Johnson Innovation-JJDC venture arm of Johnson & Johnson (…

    Published on 1/11/2016
  • FINANCIAL NEWS: Cardiorentis raises CHF60M in series B

    Cardiorentis AG (Zug, Switzerland) raised CHF60 million ($60.1 million) in a series B round. Spokesperson Kellie Walsh May said three "ultra-high net worth European investors" participated, but declined to name them.The…

    Published on 1/11/2016
  • FINANCIAL NEWS: Iconic's series C brings in $40M

    Iconic Therapeutics Inc. (Atlanta, Ga.) raised $40 million in a series C round. New investors HBM Healthcare Investments, Cormorant Asset Management and Osage University Partners joined existing investors MPM Capital, H…

    Published on 1/11/2016

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993